CLIENT NEWS
- Destiny Pharma strengthens Executive Management Team with the appointment of Dr Yuri Martina as Chief Medical Officer03 May 2022
- Abivax publishes Universal Registration Document 2022 “Document d’Enregistrement Universel”28 April 2022
- Marinomed’s Australian Carragelose distribution network strengthened28 April 2022
- Deutsches Herzzentrum München veröffentlicht erste Ergebnisse aus „Vroni-Studie“: Bayerische Pilotstudie identifiziert 76 Kinder mit bedrohlicher Cholesterinstörung27 April 2022
- Temedica wins further renowned industry representatives for expert advisory board26 April 2022
- ViGeneron announces follow-on collaboration with Daiichi Sankyo to develop a novel gene therapy for prevalent eye diseases26 April 2022
- Imcyse Announces First Patient Dosed in Adaptive Phase 1/2 Clinical Trial of ImotopeTM IMCY-0141 for Multiple Sclerosis13 April 2022
- Marinomed reports on strong 2021 financial year13 April 2022
- Secarna Pharmaceuticals’ strategic partner Evotec achieves programme designation in neuroscience collaboration with Bristol Myers Squibb12 April 2022
- Destiny Pharma plc: Audited results for the year ended 31 December 202112 April 2022